Choon Hee Chung Selected Research

Choon Hee Chung Research Topics

Disease

43	Type 2 Diabetes Mellitus (MODY) 05/2024 - 07/2006
23	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 02/2004
22	Insulin Resistance 04/2023 - 02/2007
15	Inflammation (Inflammations) 03/2024 - 06/2005
13	Albuminuria 01/2021 - 10/2007
10	Obesity 05/2024 - 09/2013
8	Non-alcoholic Fatty Liver Disease 03/2024 - 01/2009
8	Body Weight (Weight, Body) 01/2023 - 01/2006
6	Hypertension (High Blood Pressure) 10/2023 - 10/2011
6	Fibrosis (Cirrhosis) 01/2023 - 01/2015
6	Neoplasms (Cancer) 10/2021 - 06/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015 - 01/2009
4	Proteinuria 01/2015 - 02/2004
3	Dyslipidemias (Dyslipidemia) 05/2024 - 09/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2015
3	Diabetes Mellitus 01/2023 - 02/2012
3	Weight Gain 11/2022 - 01/2014
3	Kidney Diseases (Kidney Disease) 01/2019 - 11/2012
3	Hypoglycemia (Reactive Hypoglycemia) 05/2016 - 02/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2015 - 06/2011
2	Drug-Related Side Effects and Adverse Reactions 05/2024 - 11/2023
2	Fatty Liver 01/2023 - 10/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2022 - 01/2022
2	Adenoma (Adenomas) 10/2022 - 10/2021
2	Cushing Syndrome 10/2022 - 10/2021
2	Wounds and Injuries (Trauma) 01/2022 - 01/2021
2	Glucose Intolerance 01/2018 - 01/2015
2	Sarcopenia 07/2015 - 01/2015
2	Hyperinsulinism (Hyperinsulinemia) 09/2013 - 02/2004
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024
1	Idiopathic Pulmonary Fibrosis 01/2024
1	Hypokalemia 10/2023

Drug/Important Bio-Agent (IBA)

20	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2006
12	LipidsIBA 04/2023 - 01/2006
11	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 02/2007
11	Insulin (Novolin)FDA Link 01/2020 - 02/2004
8	Triglycerides (Triacylglycerol)IBA 03/2024 - 02/2006
8	CreatinineIBA 01/2021 - 02/2009
8	AlbuminsIBA 01/2021 - 02/2009
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 02/2004
6	CurcuminIBA 01/2023 - 05/2016
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2006
5	AntioxidantsIBA 01/2019 - 06/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2006
4	lobeglitazoneIBA 11/2022 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2009
4	AdiponectinIBA 01/2017 - 01/2009
3	4- (3- amino- 4- (2,4,5- trifluorophenyl)butanoyl)- 3- (tert- butoxymethyl)piperazin- 2- oneIBA 11/2023 - 01/2017
3	HDL CholesterolIBA 01/2023 - 01/2009
3	ThiazolidinedionesIBA 11/2022 - 04/2007
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 02/2012
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021 - 07/2009
3	CytokinesIBA 01/2021 - 06/2005
3	Therapeutic UsesIBA 01/2019 - 12/2011
3	Sitagliptin Phosphate (Januvia)FDA Link 10/2018 - 01/2017
3	ORALIT (ORS)IBA 01/2017 - 10/2011
3	CC ChemokinesIBA 01/2017 - 07/2013
3	Angiotensin Receptor AntagonistsIBA 10/2016 - 02/2004
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014 - 10/2012
3	C-Reactive ProteinIBA 10/2011 - 01/2009
2	oxidized low density lipoproteinIBA 05/2024 - 10/2020
2	Chemokine ReceptorsIBA 03/2024 - 01/2018
2	dapagliflozinIBA 11/2023 - 01/2023
2	glimepiride (Amarel)FDA LinkGeneric 01/2023 - 02/2007
2	GlucocorticoidsIBA 01/2023 - 02/2004
2	anagliptinIBA 01/2023 - 01/2015
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2021
2	AMP-Activated Protein KinasesIBA 01/2023 - 03/2015
2	vactosertibIBA 01/2023 - 01/2022
2	EnzymesIBA 01/2021 - 05/2009
2	NADP (NADPH)IBA 01/2021 - 02/2009
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2020 - 02/2009
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 11/2012
2	Angiotensin IIIBA 01/2019 - 02/2004
2	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2014
2	LC15-0444IBA 01/2018 - 01/2017
2	2,4-thiazolidinedione (thiazolidinedione)IBA 10/2017 - 04/2007
2	Pioglitazone (Actos)FDA Link 04/2017 - 12/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2016 - 01/2015
2	SodiumIBA 07/2015 - 01/2015
2	Uric Acid (Urate)IBA 07/2015 - 09/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 02/2007
2	nephrinIBA 07/2013 - 11/2012
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 03/2013 - 05/2009
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 05/2009 - 01/2009
2	Rosiglitazone (Avandia)FDA Link 12/2008 - 02/2007
2	AdipokinesIBA 09/2007 - 02/2007
1	Atorvastatin (Lipitor)FDA Link 05/2024
1	C-PeptideIBA 05/2024
1	recoflavoneIBA 03/2024
1	eupatilinIBA 03/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	prolyl T RNA synthetaseIBA 01/2024
1	CollagenIBA 01/2024
1	AldosteroneIBA 10/2023
1	lipoprotein cholesterolIBA 01/2023
1	Drug CombinationsIBA 01/2023

Therapy/Procedure

13	Therapeutics 05/2024 - 02/2014
3	Glycemic Control 01/2023 - 01/2015
2	Aftercare (After-Treatment) 01/2018 - 06/2015